FDA Inspection 1241713 — Dr. Rainard Fuhr, M.D.
The FDA completed an inspection of Dr. Rainard Fuhr, M.D. on May 17, 2024 in Berlin. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 17, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Berlin (Germany)
Additional Details
Clinical BA/BE